Pallas Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Pallas Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.46M	Sell	77,353 -14,911	-16%	-$856K	0.14%	126
2026 Q1	$5.6M	Sell	92,264 -3,893	-4%	-$227K	0.21%	93
2025 Q4	$5.19M	Buy	96,157 +63,750	+197%	+$3.07M	0.17%	102
2025 Q3	$1.46M	Buy	32,407 +9,972	+44%	+$466K	0.05%	259
2025 Q2	$1.04M	Sell	22,435 -3,802	-14%	-$187K	0.04%	322
2025 Q1	$1.6M	Sell	26,237 -1,101	-4%	-$64.2K	0.07%	216
2024 Q4	$1.55M	Sell	27,338 -809	-3%	-$45.2K	0.07%	171
2024 Q3	$1.49M	Buy	28,147 +9,537	+51%	+$447K	0.06%	170
2024 Q2	$789K	Buy	18,610 +9,536	+105%	+$427K	0.04%	235
2024 Q1	$492K	Buy	9,074 +2,373	+35%	+$121K	0.02%	284
2023 Q4	$344K	Sell	6,701 -207	-3%	-$10.9K	0.02%	301
2023 Q3	$354K	Buy	+6,908	New	+$423K	0.02%	273

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pallas Capital Advisors's BMY Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, selling an estimated $856K and leaving 77,353 shares worth $4.46M. The position accounts for 0.14% of the portfolio, ranked #126.

Pallas Capital Advisors first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.6M in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Pallas Capital Advisors held 77,353 shares of Bristol-Myers Squibb worth $4.46M as of Q2 2026.
Pallas Capital Advisors sold 14,911 Bristol-Myers Squibb shares in Q2 2026, an estimated $856K.
Bristol-Myers Squibb made up 0.14% of Pallas Capital Advisors's portfolio in Q2 2026, its #126 holding.
Pallas Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
Pallas Capital Advisors's Bristol-Myers Squibb position peaked at $5.6M in Q1 2026.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.